Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

Over 31 million Americans borrowed a collective $74 billion to pay for healthcare last year, a West Health-Gallup survey ...

Novo Nordisk warns of potential price hikes and shortages amid global tariff threats, impacting drug prices and supply chains ...

Dear Annie: I’ve known my friend “Ella” for over 50 years. In the last few years, for whatever reason, she only wants to ...

Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novo Nordisk (NVO – Research Report) and Veeva Systems (VEEV ...

Italian hearing aid company Amplifon reported an annual core profit margin of 23.6% on Thursday, short of its revised ...

U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could ...

Novo Nordisk (NVO) plans to study how its GLP-1 drugs marketed as Wegovy and Ozempic for obesity and diabetes can help tackle ...

Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst ...

Broadcom and Nvidia are testing Intel’s advanced chip manufacturing process, signaling potential AI chip expansion. The tests ...